Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study
Olivia Anike,Qi Zhang,Shalender Bhasin,W Dana Flanders,Darios Getahun,J Sonya Haw,Krista F Huybrechts,Timothy L Lash,Courtney E McCracken,Douglas Roblin,Michael J Silverberg,Shakira F Suglia,Vin Tangpricha,Suma Vupputuri,Michael Goodman
DOI: https://doi.org/10.1210/clinem/dgae353
2024-05-30
The Journal of Clinical Endocrinology & Metabolism
Abstract:Abstract Context The long-term effect of gender-affirming hormone therapy (GAHT) on glucose metabolism is an area of priority in transgender health research. Objectives To evaluate the relation between GAHT and changes in fasting blood glucose (FG) and glycosylated hemoglobin (HbA1c) in transmasculine (TM) and transfeminine (TF) persons relative to the corresponding temporal changes in presumably cisgender persons (i.e. without any evidence of TGD status). Design Retrospective cohort study Setting Three large integrated health systems. Participants 2,425 TF and 2,127 TM persons compared with 33,995 cisgender males (CM) and 38,913 cisgender females (CF) enrolled in the same health plans. Outcomes/measures Temporal changes in FG and HbA1c levels examined using linear mixed models with main results expressed as ratios-of-ratios. Results The pre- versus post-GAHT ratios-of-ratio (95% confidence interval) estimates adjusted for age, race/ethnicity, study site, and body mass index in the model comparing TF and CM groups were 1.05 (1.01, 1.09) for FG and 1.03 (0.99, 1.06) for HbA1c. By contrast, the corresponding results in the models contrasting TM and cisgender cohort members were in the 0.99-1.00 range. The ratio-of-ratios comparing post-GAHT changes among transgender and cisgender persons were close to the null and without a discernable pattern. Conclusion Though the within-transgender cohort data suggest an increase in the levels of FG and HbA1c following feminizing GAHT initiation, these changes were no longer evident when compared with the corresponding changes in cisgender referents. Based on these results, clinically important effects of GAHT on routine laboratory markers of glucose metabolism appear unlikely.
endocrinology & metabolism